Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis

por Neuberger, Edward E., Abbass, Ibrahim M., Jones, Eddie, Engmann, Natalie J.
Publicado 2020

Patients’ access to rare neuromuscular disease therapies varies across US private insurers

por Margaretos, Nikoletta M., Bawa, Komal, Engmann, Natalie J., Chambers, James D.
Publicado 2022

Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data

por Engmann, Natalie J, Sheinson, Danny, Bawa, Komal, Ng, Carmen D, Pardo, Gabriel
Publicado 2021

An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability

por Wolinsky, Jerry S, Engmann, Natalie J, Pei, Jinglan, Pradhan, Ashish, Markowitz, Clyde, Fox, Edward J
Publicado 2020

Population Health Science: A Core Element of Health Science Education in Sub-Saharan Africa

por Hiatt, Robert A., Engmann, Natalie J., Ahmed, Mushtaq, Amarsi, Yasmin, Macharia, William M., Macfarlane, Sarah B., Ngugi, Anthony K., Rabbani, Fauziah, Walraven, Gijs, Armstrong, Robert W.
Publicado 2017

A complex systems model of breast cancer etiology: The Paradigm II Model

por Hiatt, Robert A., Worden, Lee, Rehkopf, David, Engmann, Natalie, Troester, Melissa, Witte, John S., Balke, Kaya, Jackson, Christian, Barlow, Janice, Fenton, Suzanne E., Gehlert, Sarah, Hammond, Ross A., Kaplan, George, Kornak, John, Nishioka, Krisida, McKone, Thomas, Smith, Martyn T., Trasande, Leonardo, Porco, Travis C.
Publicado 2023

Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer

por Brandt, Kathleen R., Scott, Christopher G., Miglioretti, Diana L., Jensen, Matthew R., Mahmoudzadeh, Amir P., Hruska, Carrie, Ma, Lin, Wu, Fang Fang, Cummings, Steven R., Norman, Aaron D., Engmann, Natalie J., Shepherd, John A., Winham, Stacey J., Kerlikowske, Karla, Vachon, Celine M.
Publicado 2019